AUS
NZ
UK
CA
USA
IND
Healthcare
ASX 200 Telix Pharmaceuticals shares surge on half year performance update
August 23, 2025 09:13 PM AEST| By Team Kalkine MediaHighlights,Telix Pharmaceuticals (ASX:TLX) recorded strong half year performance with revenue growth and margin stability,The company reaffirmed its full year guidance with upcoming product approvals and submissions in focus,Shares of Telix climbed w...
Ramsay Health Care Faces Growth Challenges Within ASX 200 Landscape
August 23, 2025 08:50 PM AEST| By Team Kalkine MediaHighlights,Ramsay Health Care shows slower revenue expansion compared to industry peers,Market sentiment weighs on its valuation due to growth concerns,Future outlook raises questions about competitive positioning,Ramsay Health Care Limited (ASX:RHC)...
Sonic Healthcare (ASX:SHL) and its Place in the ASX 200 Index: A Closer Look at 2025
August 23, 2025 08:40 PM AEST| By Team Kalkine MediaHighlights,Sonic Healthcare (SHL) remains a key player in global healthcare.,The company offers diverse medical and diagnostic services.,Valuation metrics highlight its performance and capital health.,Sonic Healthcare (ASX:SHL) is a leading player in...
ASX 200 Healthcare Sector Faces Heavy Setback as CSL and Sonic Lead Declines
August 22, 2025 06:26 PM AEST| By Team Kalkine MediaHighlights,Healthcare companies on the Australian market index recorded sharp declines despite gains across the broader benchmark,CSL (ASX:CSL) faced its steepest fall after unveiling restructuring plans and a vaccine business separation,Sonic Health...
Indexasx xjo Sonic Healthcare (ASX:SHL) movement after FY results update
August 22, 2025 04:09 PM AEST| By Team Kalkine MediaHighlights,Sonic Healthcare (ASX:SHL) shares recorded a notable decline following its FY results release,The healthcare group reported growth in revenue and operating profit but earnings after tax remained largely unchanged,Guidance pointed towards s...
Artrya’s (ASX:AYA) Cash Strategy and Market Outlook Beyond the ASX 200
August 22, 2025 03:48 PM AEST| By Team Kalkine MediaHighlights,Artrya focuses on managing its cash position effectively,Company shows signs of controlling expenditure,Market outlook depends on future funding and operational progress,Artrya (ASX:AYA) has been gaining attention for its innovative work i...
LTR Pharma Advances SPONTAN Shelf Life Extension Amid ASX 200 Healthcare Landscape
August 22, 2025 01:17 PM AEST| By Team Kalkine MediaHighlights,LTR Pharma (LTP) extends shelf life of SPONTAN spray,Stability supports global distribution readiness,Clinical data reinforces rapid onset performance,LTR Pharma (ASX:LTP) has achieved an important step forward with its erectile dysfunctio...
Sonic Healthcare Faces Pressure After FY25 Results, Spotlight on ASX 200
August 22, 2025 12:48 PM AEST| By Team Kalkine MediaHighlights,Sonic Healthcare (SHL) reports full-year results.,Mixed performance across global divisions.,Market reacts cautiously to guidance.,Sonic Healthcare (ASX:SHL), a major player in global pathology services, released its FY25 financial results...
Artrya Ltd Gains Strong Momentum on FDA Approval Amid ASX 200 Market Focus
August 21, 2025 08:16 PM AEST| By Team Kalkine MediaHighlights,Artrya Ltd (ASX:AYA) secures FDA approval for diagnostic platform,Expansion into U.S. healthcare market through strategic partnerships,Growing commercial opportunities with AI-powered heart disease detection,Artrya Ltd (ASX:AYA) has recent...
Tryptamine Therapeutics Signs Landmark Deal to Advance Precision Psychiatry Research with Focus Beyond ASX 200
August 21, 2025 04:47 PM AEST| By Team Kalkine MediaHighlights,Tryptamine Therapeutics enters agreement for precision psychiatry.,Collaboration with Imperial College London experts.,Development of EEG-based biomarker platform to advance mental health treatment.,Tryptamine Therapeutics (ASX:TRP) has ta...
ASX 200 steadies as banks lift gains after CSL impact on healthcare sector
August 21, 2025 03:12 PM AEST| By Team Kalkine MediaHighlights,Banks and real estate stocks supported the market recovery within the ASX 200,Healthcare stocks eased after CSL (ASX:CSL) continued to weigh on sentiment,High-profile moves were seen across companies including HMC Capital (ASX:HMC), James...
Artrya Gains FDA Clearance for Salix Coronary Plaque Module Amid ASX 200 Landscape
August 21, 2025 11:56 AM AEST| By Team Kalkine MediaHighlights,Artrya (AYA) secures FDA clearance for its Salix Coronary Plaque Module,Approval paves way for wider integration across US hospital systems,Technology offers faster detection and enhanced workflow efficiency,Artrya (ASX:AYA) has achieved a...
ResMed (ASX:RMD) Share Price Outlook: Exploring Healthcare Opportunities in the ASX 200
August 21, 2025 11:33 AM AEST| By Team Kalkine MediaHighlights,ResMed (RMD) focuses on medical devices and SaaS healthcare solutions,Healthcare sector known for consistent revenue streams,Global demand for healthcare technology continues to expand,Healthcare companies often stand out among,ASX 200 com...
Tryp Advances Precision Psychiatry with Exclusive EEG-Based Biomarker Agreement
August 21, 2025 11:05 AM AEST| By Team Kalkine MediaHighlights,Tryp enters exclusive agreement to develop EEG biomarker,Biomarker aims to enhance therapeutic outcomes for TRP-8803,Collaboration integrates neuroscience with real-time data analysis,Tryptamine Therapeutics Ltd (ASX:TYP) has taken a major...
Lumos Diagnostics ASX:LDX CLIA Waiver Progress Strengthens Position in ASX 200 Index
August 20, 2025 04:13 PM AEST| By Team Kalkine MediaHighlights,Lumos Diagnostics (ASX:LDX) advanced its regulatory pathway with a CLIA waiver submission for FebriDx in the United States.,The company secured milestone and prepayment inflows linked to the regulatory filing and partnership agreements.,Br...
Lumos Diagnostics Advances FebriDx Pathway with FDA Waiver Bid
August 20, 2025 04:09 PM AEST| By Team Kalkine MediaHighlights,Lumos Diagnostics submits CLIA waiver application for FebriDx.,Broader US market access anticipated upon approval.,Strategic focus on reimbursement support and adoption.,Lumos Diagnostics (ASX:LDX) has taken a significant step forward with...
CSL Shares Impact asx 200 After Mixed Fiscal Update
August 20, 2025 03:08 PM AEST| By Team Kalkine MediaHighlights,CSL (ASX:CSL) shares moved lower after reporting a mixed yearly outcome,Revenue and earnings fell short of consensus while net profit aligned with company guidance,Company announced restructuring with workforce adjustments and strategic ch...
ASX Higher Despite CSL Shares Falling and James Hardie Nosedive – Australian Share Market Today
August 20, 2025 02:30 PM AEST| By Team Kalkine MediaHighlights,Major banks and financial stocks led the upward movement in the Australian share market.,CSL (ASX:CSL) experienced a second day of decline following its reporting season results.,James Hardie (ASX:JHX) shares dropped amid a profit slump.,T...
Insider Ownership Drives Confidence in Mesoblast Limited (ASX:MSB)
August 20, 2025 11:48 AM AEST| By Team Kalkine MediaHighlights,Insider ownership holds strong influence in Mesoblast Limited,Institutions show notable interest in the company’s position,General public remains a significant part of the shareholder base,The dynamics of shareholder structures often play...
CSL (ASX:CSL) Shake-Up Sends Ripples Across ASX 200
August 20, 2025 10:26 AM AEST| By Team Kalkine MediaHighlights,CSL (CSL) share price experiences sharp decline,Transformation plan and restructuring raise concerns,Broader ASX 200 index also feels the impact,CSL Limited (ASX:CSL), one of the leading,ASX 200 companies,, recently surprised the market wi...
Advertise your brand on Kalkine Media